Logo image of RAY

RAYTECH HOLDING LTD (RAY) Stock Fundamental Analysis

NASDAQ:RAY - Nasdaq - VGG7385S1011 - Common Stock - Currency: USD

1.28  +0.05 (+4.07%)

After market: 1.3 +0.02 (+1.56%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to RAY. RAY was compared to 17 industry peers in the Distributors industry. RAY is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. RAY has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year RAY was profitable.
RAY had a positive operating cash flow in the past year.
RAY Yearly Net Income VS EBIT VS OCF VS FCFRAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 15.23%, RAY belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
RAY's Return On Equity of 19.89% is fine compared to the rest of the industry. RAY outperforms 76.47% of its industry peers.
RAY has a better Return On Invested Capital (16.88%) than 82.35% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for RAY is significantly above the industry average of 20.31%.
The last Return On Invested Capital (16.88%) for RAY is well below the 3 year average (38.47%), which needs to be investigated, but indicates that RAY had better years and this may not be a problem.
Industry RankSector Rank
ROA 15.23%
ROE 19.89%
ROIC 16.88%
ROA(3y)27.12%
ROA(5y)N/A
ROE(3y)41.78%
ROE(5y)N/A
ROIC(3y)38.47%
ROIC(5y)N/A
RAY Yearly ROA, ROE, ROICRAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60 80

1.3 Margins

With an excellent Profit Margin value of 13.24%, RAY belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
RAY's Profit Margin has declined in the last couple of years.
The Operating Margin of RAY (13.86%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of RAY has declined.
The Gross Margin of RAY (21.82%) is comparable to the rest of the industry.
RAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.86%
PM (TTM) 13.24%
GM 21.82%
OM growth 3Y-7.01%
OM growth 5YN/A
PM growth 3Y-5.63%
PM growth 5YN/A
GM growth 3Y-3.56%
GM growth 5YN/A
RAY Yearly Profit, Operating, Gross MarginsRAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15 20 25

More info and screens

10

2. Health

2.1 Basic Checks

RAY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, RAY has less shares outstanding
There is no outstanding debt for RAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RAY Yearly Shares OutstandingRAY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
RAY Yearly Total Debt VS Total AssetsRAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

RAY has an Altman-Z score of 7.66. This indicates that RAY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of RAY (7.66) is better than 88.24% of its industry peers.
There is no outstanding debt for RAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.66
ROIC/WACC1.81
WACC9.34%
RAY Yearly LT Debt VS Equity VS FCFRAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

A Current Ratio of 4.27 indicates that RAY has no problem at all paying its short term obligations.
RAY's Current ratio of 4.27 is amongst the best of the industry. RAY outperforms 82.35% of its industry peers.
RAY has a Quick Ratio of 4.22. This indicates that RAY is financially healthy and has no problem in meeting its short term obligations.
RAY has a Quick ratio of 4.22. This is amongst the best in the industry. RAY outperforms 88.24% of its industry peers.
Industry RankSector Rank
Current Ratio 4.27
Quick Ratio 4.22
RAY Yearly Current Assets VS Current LiabilitesRAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

5

3. Growth

3.1 Past

RAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.86%, which is quite impressive.
Measured over the past years, RAY shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.56% on average per year.
RAY shows a strong growth in Revenue. In the last year, the Revenue has grown by 40.35%.
RAY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.10% yearly.
EPS 1Y (TTM)21.86%
EPS 3Y24.56%
EPS 5YN/A
EPS Q2Q%-28%
Revenue 1Y (TTM)40.35%
Revenue growth 3Y28.1%
Revenue growth 5YN/A
Sales Q2Q%30.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RAY Yearly Revenue VS EstimatesRAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

RAY is valuated reasonably with a Price/Earnings ratio of 11.64.
82.35% of the companies in the same industry are more expensive than RAY, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of RAY to the average of the S&P500 Index (26.55), we can say RAY is valued rather cheaply.
Industry RankSector Rank
PE 11.64
Fwd PE N/A
RAY Price Earnings VS Forward Price EarningsRAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

94.12% of the companies in the same industry are more expensive than RAY, based on the Enterprise Value to EBITDA ratio.
RAY's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 90.43
EV/EBITDA 5.81
RAY Per share dataRAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

RAY has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RAY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RAYTECH HOLDING LTD

NASDAQ:RAY (6/11/2025, 5:58:50 PM)

After market: 1.3 +0.02 (+1.56%)

1.28

+0.05 (+4.07%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner ChangeN/A
Ins Owners77.22%
Ins Owner ChangeN/A
Market Cap22.54M
AnalystsN/A
Price TargetN/A
Short Float %10.32%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.64
Fwd PE N/A
P/S 1.61
P/FCF 90.43
P/OCF 90.43
P/B 2.41
P/tB 2.41
EV/EBITDA 5.81
EPS(TTM)0.11
EY8.59%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY1.11%
OCF(TTM)0.01
OCFY1.11%
SpS0.8
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 15.23%
ROE 19.89%
ROCE 20.83%
ROIC 16.88%
ROICexc N/A
ROICexgc N/A
OM 13.86%
PM (TTM) 13.24%
GM 21.82%
FCFM 1.77%
ROA(3y)27.12%
ROA(5y)N/A
ROE(3y)41.78%
ROE(5y)N/A
ROIC(3y)38.47%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)47.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-7.01%
OM growth 5YN/A
PM growth 3Y-5.63%
PM growth 5YN/A
GM growth 3Y-3.56%
GM growth 5YN/A
F-Score4
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 12.77%
Profit Quality 13.41%
Current Ratio 4.27
Quick Ratio 4.22
Altman-Z 7.66
F-Score4
WACC9.34%
ROIC/WACC1.81
Cap/Depr(3y)10.4%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.01%
Cap/Sales(5y)N/A
Profit Quality(3y)139.91%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.86%
EPS 3Y24.56%
EPS 5YN/A
EPS Q2Q%-28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.35%
Revenue growth 3Y28.1%
Revenue growth 5YN/A
Sales Q2Q%30.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.94%
EBIT growth 3Y19.13%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y43.67%
FCF growth 3Y33.13%
FCF growth 5YN/A
OCF growth 1Y43.67%
OCF growth 3Y32.99%
OCF growth 5YN/A